Resveratrol, ciglitazone and troglitazone were found to induce E3 ubiquitin ligases in triple-negative breast cancer cells with β-TrCP expression, thereby decreasing PD-L1 protein expression in cancer cells[16]. This evidence concerns the gene CD274 and cancer.